MPLX LP vs Twist Bioscience Corp — how do they compare? MPLX LP trades at $56.64 (market cap $57.97B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: MPLX LP is far larger — about 10.6× Twist Bioscience Corp's market cap, and MPLX LP pays a 7.54% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| MPLX | TWST | |
|---|---|---|
Market Cap | $57.97B | $5.45B |
Sector | Technology | Health |
52-Week High | $59.17 | $102.88 |
52-Week Low | $47.80 | $24.16 |
Enterprise Value | $82.60B | $5.37B |
Dividend Yield | 7.54% | — |
Trailing returns across standard periods
Latest headlines on both assets
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →